Completing data — refresh the page later to see the latest
16874-33-2O=C(O)C1CCCO1UJJLJRQIPMGXEZ-UHFFFAOYSA-Nstructure given in first source; RN given refers to cpd without isomeric designation
16874-33-2DTXSID601030927CHEMBL4447232Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Danger
H302 (94.4%): Harmful if swallowed [Warning Acute toxicity, oral]
P260, P264, P270, P280, P301+P317, P301+P330+P331, P302+P361+P354, P304+P340, P305+P354+P338, P316, P321, P330, P363, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 126 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
REACH registered substance: oxolane-2-carboxylic acid (EC: 605-530-1)
2-Tetrahydrofuran carboxylic acid: Does not have an individual approval but may be used under an appropriate group standard
Uses2-Tetrahydrofuroic acid is used as a reagent to synthesize Alfuzosin (HCl: A532000), an unselective alpha-1 blocker that is used to treat lower urinary tract symptoms and benign prostatic hyperplasia.
General DescriptionTetrahydro-2-furoic acid inhibits the programmed cell death of Xanthomonas campestris strains. It is a specific inhibitor of proline dehydrogenase, a mitochondrial flavoenzyme that oxidizes proline.
Loading…